Showing results (61-70 of 771) with videos related to
Sort By:
Pageof 78
Cell Stem Cell|February 7, 2012
Hematopoietic-stem-cell-based gene therapy for HIV diseaseHans-Peter Kiem, Keith R Jerome, Steven G Deeks, et al.The Journal of Infectious Diseases|November 17, 2006
Treatment benefit on cerebrospinal fluid HIV-1 levels in the setting of systemic virological suppression and failureSerena Spudich, Nicole Lollo, Teri Liegler, et al.The Journal of Infectious Diseases|May 13, 2017
HIV Antibody Level as a Marker of HIV Persistence and Low-Level Viral ReplicationSheila M Keating, Christopher D Pilcher, Vivek Jain, et al.Plos One|September 30, 2009
The risk of virologic failure decreases with duration of HIV suppression, at greater than 50% adherence to antiretroviral therapyMichael Rosenblum, Steven G Deeks, Mark van der Laan, et al.AIDS Research and Therapy|August 20, 2005
Cerebrospinal fluid signs of neuronal damage after antiretroviral treatment interruption in HIV-1 infectionMagnus Gisslén, Lars Rosengren, Lars Hagberg, et al.Nature Immunology|February 25, 2022
Fighting the SARS-CoV-2 pandemic requires a global approach to understanding the heterogeneity of vaccine responsesJeffrey A Tomalka, Mehul S Suthar, Steven G Deeks, et al.AIDS (London, England)|January 25, 2002
Duration and predictors of CD4 T-cell gains in patients who continue combination therapy despite detectable plasma viremiaSteven G Deeks, Jason D Barbour, Robert M Grant, et al.The Journal of Infectious Diseases|March 4, 2014
Low proportions of CD28- CD8+ T cells expressing CD57 can be reversed by early ART initiation and predict mortality in treated HIV infectionSulggi A Lee, Elizabeth Sinclair, Vivek Jain, et al.Indian Journal of Dermatology, Venereology and Leprology|May 9, 2012
Doing meta-analysis in research: a systematic approachVivek Jain, Rinku Sharma, Saudan SinghJournal of Tropical Pediatrics|August 22, 2003
Pediatric emergencies at a tertiary care hospital in IndiaSunit Singhi, Vivek Jain, Gaurav GuptaPageof 78